174 related articles for article (PubMed ID: 33361301)
1. Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.
Aedo SJ; Tang J; Brynildsen MP
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361301
[TBL] [Abstract][Full Text] [Related]
2. Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli.
Ho PL; Ng KY; Lo WU; Law PY; Lai EL; Wang Y; Chow KH
Antimicrob Agents Chemother; 2016 Jan; 60(1):537-43. PubMed ID: 26552976
[TBL] [Abstract][Full Text] [Related]
3. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
[TBL] [Abstract][Full Text] [Related]
4. Prediction of nitrofurantoin resistance among Enterobacteriaceae and mutational landscape of in vitro selected resistant Escherichia coli.
Khamari B; Adak S; Chanakya PP; Lama M; Peketi ASK; Gurung SA; Chettri S; Kumar P; Bulagonda EP
Res Microbiol; 2022; 173(1-2):103889. PubMed ID: 34718096
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and nitrofurantoin resistance determinants of nitrofurantoin-non-susceptible Escherichia coli isolated from urinary tract infections.
Mottaghizadeh F; Mohajjel Shoja H; Haeili M; Darban-Sarokhalil D
J Glob Antimicrob Resist; 2020 Jun; 21():335-339. PubMed ID: 31627025
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal Cooperation of Type A Procyanidin and Nitrofurantoin Against Multi-Drug Resistant (MDR) UPEC: A pH-Dependent Study.
Vasudevan S; Thamil Selvan G; Bhaskaran S; Hari N; Solomon AP
Front Cell Infect Microbiol; 2020; 10():421. PubMed ID: 32850505
[TBL] [Abstract][Full Text] [Related]
7. Nitrofurantoin Combined With Amikacin: A Promising Alternative Strategy for Combating MDR Uropathogenic
Zhong ZX; Cui ZH; Li XJ; Tang T; Zheng ZJ; Ni WN; Fang LX; Zhou YF; Yu Y; Liu YH; Liao XP; Sun J
Front Cell Infect Microbiol; 2020; 10():608547. PubMed ID: 33409159
[TBL] [Abstract][Full Text] [Related]
8. An update on the role of nitrofurans in the management of urinary tract infections.
Guay DR
Drugs; 2001; 61(3):353-64. PubMed ID: 11293646
[TBL] [Abstract][Full Text] [Related]
9. Peptidoglycan Sensing Prevents Quiescence and Promotes Quorum-Independent Colony Growth of Uropathogenic Escherichia coli.
DiBiasio EC; Ranson HJ; Johnson JR; Rowley DC; Cohen PS; Camberg JL
J Bacteriol; 2020 Sep; 202(20):. PubMed ID: 32778561
[TBL] [Abstract][Full Text] [Related]
10. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
Arredondo-García JL; Amábile-Cuevas CF
J Infect Dev Ctries; 2008 Oct; 2(5):350-3. PubMed ID: 19745501
[TBL] [Abstract][Full Text] [Related]
11. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
Asadi Karam MR; Habibi M; Bouzari S
Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
[TBL] [Abstract][Full Text] [Related]
12. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
13. [Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences].
El Bouamri MC; Arsalane L; Kamouni Y; Yahyaoui H; Bennouar N; Berraha M; Zouhair S
Prog Urol; 2014 Dec; 24(16):1058-62. PubMed ID: 25310915
[TBL] [Abstract][Full Text] [Related]
14. Outcome of acute urinary tract infections caused by uropathogenic
Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
[TBL] [Abstract][Full Text] [Related]
15. Rapid Growth of Uropathogenic
Forsyth VS; Armbruster CE; Smith SN; Pirani A; Springman AC; Walters MS; Nielubowicz GR; Himpsl SD; Snitkin ES; Mobley HLT
mBio; 2018 Mar; 9(2):. PubMed ID: 29511075
[TBL] [Abstract][Full Text] [Related]
16. Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in an uropathogenic Klebsiella pneumoniae isolate.
Xu Q; Jiang J; Zhu Z; Xu T; Sheng ZK; Ye M; Xu X; Wang M
Int J Antimicrob Agents; 2019 Aug; 54(2):223-227. PubMed ID: 31200021
[TBL] [Abstract][Full Text] [Related]
17. Payload hardware and experimental protocol development to enable future testing of the effect of space microgravity on the resistance to gentamicin of uropathogenic Escherichia coli and its σ
Matin AC; Wang JH; Keyhan M; Singh R; Benoit M; Parra MP; Padgen MR; Ricco AJ; Chin M; Friedericks CR; Chinn TN; Cohen A; Henschke MB; Snyder TV; Lera MP; Ross SS; Mayberry CM; Choi S; Wu DT; Tan MX; Boone TD; Beasley CC; Piccini ME; Spremo SM
Life Sci Space Res (Amst); 2017 Nov; 15():1-10. PubMed ID: 29198308
[TBL] [Abstract][Full Text] [Related]
18. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens.
McOsker CC; Fitzpatrick PM
J Antimicrob Chemother; 1994 May; 33 Suppl A():23-30. PubMed ID: 7928834
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic Resistance Among Uropathogenic
Kot B
Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885
[TBL] [Abstract][Full Text] [Related]
20. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
